Search results for: meth

  Mary McCarty-Arias, M.A. Research Project Manager Division of Substance Use Disorders New York State Psychiatric Institute Department of Psychiatry, Columbia University Medical Center This course is a supplement to the National Core Curriculum recent work on Stimulants and their Impact on Brain and Behavior: Best Practices and Approaches for Effective Treatment and Recovery. This training focuses on MSM (men who have sex with men) and the connection with HIV and methamphetamines. It presents epidemiology, reasons why methamphetamine use is prevalent in the MSM community and the effects of methamphetamines on HIV progression.

The goal of the NIDA Clinical Trials Network and Addiction Technology Transfer Center (ATTC) webinar series is to help scholars and clinicians in the addiction field stay abreast of cutting edge science. In this session, Larissa Mooney, MD, one of two PIs for the Greater Southern California Node of

The goal of the NIDA Clinical Trials Network and Addiction Technology Transfer Center (ATTC) webinar series is to help scholars and clinicians in the addiction field stay abreast of cutting edge science. In this session, Larissa Mooney, MD, one of two PIs for the Greater Southern California Node of the NIDA Clinical Trials Network, will discuss recent trends in co-occurring methamphetamine use and opioid use disorder (OUD), including overdose fatalities. Participants will also learn about the treatment approaches to address this rising comorbidity. Learning objectives Recall at least two recent epidemiological trends in co-occurring methamphetamine use and opioid use disorder. Identify at least three medical risks of co-occurring methamphetamine and opioid use. Explain at least three evidence-based treatment approaches that can be utilized with patients who use both methamphetamine and opioids. 1.5 CME or CE credits available: AMA PRA Category 1 CreditsTM; PSY (APA); RN (CA BRN); LMFT, LCSW, LPCC, LEP (CAMFT); RADT I/II, CADC-CAS, CADC I/II, CADC-CS, LAADC (CCAPP); CATC (ACCBC/CAADE); CAODC (CADTP) Please note: You must select the type of credits you would like to receive on the registration form; this information cannot be modified later. Zoom will track your attendance automatically; only those who attend the complete (live) event will be awarded credits (no partial credits available). Sponsored by the Northwest and Pacific Southwest Addiction Technology Transfer Centers (ATTCs) and the Western States Node of the NIDA Clinical Trials Network. Download flyer (includes information about CME and CE accreditation)  

Mary McCarty-Arias, M.A. Research Project Manager Division of Substance Use Disorders New York State Psychiatric Institute Department of Psychiatry, Columbia University Medical Center This course is a supplement to the National Core Curriculum recent work on Stimulants and their Impact on Brain and Behavior: Best Practices and Approaches for Effective Treatment and Recovery. This training focuses on MSM (men who have sex with men) and the connection with HIV and methamphetamines. It presents epidemiology, reasons why methamphetamine use is prevalent in the MSM community and the effects of methamphetamines on HIV progression.  

Mary McCarty-Arias, M.A. Research Project Manager Division of Substance Use Disorders New York State Psychiatric Institute Department of Psychiatry, Columbia University Medical Center   This course is a supplement to the National Core Curriculum recent work on Stimulants and their Impact on Brain and Behavior: Best Practices and Approaches for Effective Treatment and Recovery. This training focuses on MSM (men who have sex with men) and the connection with HIV and methamphetamines. It presents epidemiology, reasons why methamphetamine use is prevalent in the MSM community and the effects of methamphetamines on HIV progression.

This course is a supplement to the National Core Curriculum recent work on Stimulants and their Impact on Brain and Behavior: Best Practices and Approaches for Effective Treatment and Recovery. This training focuses on MSM (men who have sex with men) and the connection with HIV and methamphetamines. It presents epidemiology, reasons why methamphetamine use is prevalent in the MSM community and the effects of methamphetamines on HIV progression. This training meets the requirements for two renewal hours (CASAC, CPP, CPS) and two initial hours (CPP, CPS) through New York State’s Office of Addiction Services and Supports (NYS OASAS).

Presenters: Ali Jalali, PhD, Kathryn E. McCollister, PhD, Sean M. Murphy, PhD ABSTRACT:  This CHERISH (Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV) sponsored seminar will provide an in-depth review of methods for conducting an economic evaluation alongside a clinical trial. Statistical methods frequently employed in applied health econometric studies (two-part, and generalized linear models, recycled predictions, mixed effects, longitudinal analysis, etc.), and best practices for data collection and analysis will be discussed, with examples using Stata statistical software; however, experience with Stata is not a prerequisite. This seminar is designed for investigators who have some familiarity with economic evaluations, but would benefit from a more detailed outline of the methods involved and examples of their application.

Motivated by the context of opioid policy research, this workshop will provide an overview of key methodological challenges faced when evaluating the effectiveness of state-level policy using annual state- level data, as well as potential solutions and practice guidelines. We will begin discussing the commonly used linear difference-in-difference (DID) model and then subsequently discuss DID extensions and alternative approaches (i.e., autoregressive models, non-linear models, doubly robust methods, synthetic controls). Methods will be demonstrated in STATA using an opioid policy case study.

This CHERISH (Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV) sponsored seminar will provide an in-depth review of methods for conducting an economic evaluation alongside a clinical trial. Statistical methods frequently employed in applied health econometric studies (two-part, and generalized linear models, recycled predictions, mixed effects, longitudinal analysis, etc.), and best practices for data collection and analysis will be discussed, with examples using Stata statistical software; however, experience with Stata is not a prerequisite. This seminar is designed for investigators who have some familiarity with economic evaluations, but would benefit from a more detailed outline of the methods involved and examples of their application.

Presenters: Megan Schuler, PhD, and Beth Ann Griffin, PhD ABSTRACT: Motivated by the context of opioid policy research, this workshop will provide an overview of key methodological challenges faced when evaluating the effectiveness of state-level policy using annual state- level data, as well as potential solutions and practice guidelines. We will begin discussing the commonly used linear difference-in-difference (DID) model and then subsequently discuss DID extensions and alternative approaches (i.e., autoregressive models, non-linear models, doubly robust methods, synthetic controls). Methods will be demonstrated in STATA using an opioid policy case study.

The Addiction Health Services Research Monthly Workshops continue with the December workshop, "Methods Workshop: State-Level Opioid Policy Analyses: Moving Beyond the Classic Difference-in-Difference Model" with presenters, Megan Schuler, PhD, and Beth Ann Griffin, PhD. ABSTRACT: Motivated by the context of opioid policy research, this workshop will provide an overview of key methodological challenges faced when evaluating the effectiveness of state-level policy using annual state- level data, as well as potential solutions and practice guidelines. We will begin discussing the commonly used linear difference-in-difference (DID) model and then subsequently discuss DID extensions and alternative approaches (i.e., autoregressive models, non-linear models, doubly robust methods, synthetic controls). Methods will be demonstrated in STATA using an opioid policy case study.

The Mountain Plains ATTC Co-Director, Professor Thomasine Heitkamp, served as emcee for the virtual South Dakota METH SUMMIT III: CONNECTING TO SOLUTION on October 21, 2020, hosted by the South Dakota Department of Tribal Relations and Department of Social Services. This virtual event was invitation

Crystal methamphetamine use is growing increasingly common among men who have sex with men (MSM) in the northeastern U.S. and is an important public health concern. This webinar, presented by Adam Viera, PhD student (Yale University), shares preliminary themes emerging from a qualitative study of MSM who use crystal methamphetamine. These themes present important lessons for treatment organizations looking to address crystal meth use among MSM. Download slides | Watch recording Webinar category: Specific populations

In this webinar in February 2020, Dr. Robrina Walker, University of Texas Southwestern Medical Center, described trends in the use of methamphetamine, presented about evidence-based treatments for methamphetamine use disorder, and summarized current research investigating new treatments for methamphetamine use disorder. This event was co-sponsored by the Western States Node of the NIDA Clinical Trials Network. Download slides | Watch recording

Join us on March 25 from 12-1pm (PT) for our next Northwest ATTC webinar:  Substance Use Treatment Perceptions and Experiences Among Men Who Have Sex with Men Who Use Crystal Methamphetamine Crystal methamphetamine use is growing increasingly common among men who have sex with men (MSM) in the

Crystal methamphetamine use is growing increasingly common among men who have sex with men (MSM) in the northeastern U.S. and is an important public health concern. Presented by Adam Viera, PhD student at Yale University School of Public Health, this webinar will share preliminary themes emerging from a qualitative study of MSM who use crystal methamphetamine. These themes present important lessons for treatment organizations looking to address crystal meth use among MSM. Download/share flyer

Please join the Northwest ATTC and the Western States Node of the NIDA Clinical Trials Network for our next joint webinar on February 25, 2020 (11am - 12:30pm PT)! Presented by Robina Walker, PhD, of the University of Texas Southwestern Medical Center, this webinar will desc

Please join the Northwest ATTC and the Western States Node of the NIDA Clinical Trials Network for our next joint webinar on February 25, 2020! Presented by Robina Walker, PhD, of the University of Texas Southwestern Medical Center, this webinar will describe trends in the use of methamphetamine, describe evidence-based treatments for methamphetamine use disorder, and summarize current research investigating new treatments for methamphetamine use disorder. 1.5 NAADAC CEU will be available for those who attend the live webinar! For more information, download our flyer!